Fibroblast growth factor control of cartilage homeostasis.
Fibroblast growth factor control of cartilage homeostasis.
复制标题
DOI:
10.1002/jcb.24418
复制
发表时间:
2013-04
影响因子:
4
通讯作者:
Im, H. J.
中科院分区:
文献类型:
--
作者:
Ellman, M. B.;Yan, D.;Ahmadinia, K.;Chen, D.;An, H. S.;Im, H. J.
Osteoarthritis (OA) and degenerative disc disease (DDD) are similar diseases involving the breakdown of cartilage tissue, and a better understanding of the underlying biochemical processes involved in cartilage degeneration may allow for the development of novel biologic therapies aimed at slowing the disease process. Three members of the fibroblast growth factor (FGF) family, FGF-2, FGF-18, and FGF-8, have been implicated as contributing factors in cartilage homeostasis. The role of FGF-2 is controversial in both articular and intervertebral disc (IVD) cartilage as it has been associated with species- and age-dependent anabolic or catabolic events. Recent evidence suggests that FGF-2 selectively activates FGF receptor 1 (FGFR1) to exert catabolic effects in human articular chondrocytes and IVD tissue via upregulation of matrix-degrading enzyme production, inhibition of extracellular matrix (ECM) accumulation and proteoglycan synthesis, and clustering of cells characteristic of arthritic states. FGF-18, on the other hand, most likely exerts anabolic effects in human articular chondrocytes by activating the FGFR3 pathway, inducing ECM formation and chondrogenic cell differentiation, and inhibiting cell proliferation. These changes result in dispersed chondrocytes or disc cells surrounded by abundant matrix. The role of FGF-8 has recently been identified as a catabolic mediator in rat and rabbit articular cartilage, but its precise biological impact on human adult articular cartilage or IVD tissue remains unknown. The available evidence reveals the promise of FGF-2/FGFR1 antagonists, FGF-18/FGFR3 agonists, and FGF-8 antagonists (i.e., anti-FGF-8 antibody) as potential therapies to prevent cartilage degeneration and/or promote cartilage regeneration and repair in the future.
登录
查看更多内容
影响因子:
2.3
作者:
Madry, Henning;Orth, Patrick;Cucchiarini, Magali
通讯作者:
Cucchiarini, Magali
影响因子:
7
作者:
Chuma, H;Mizuta, H;Hiraki, Y
通讯作者:
Hiraki, Y
影响因子:
--
作者:
Li, Xin;Ellman, Michael;Muddasani, Prasuna;Wang, James H. -C.;Cs-Szabo, Gabriella;van Wijnen, Andre J.;Im, Hee-Jeong
通讯作者:
Im, Hee-Jeong
DOI:
10.1038/nrd2792
发表时间:
2009-03
期刊:
Nature reviews. Drug discovery
影响因子:
--
作者:
通讯作者:
--
影响因子:
7
作者:
Ellsworth, JL;Berry, J;Hughes, SD
通讯作者:
Hughes, SD